Status:
UNKNOWN
ECMO for Critically Ill Patients With Respiratory Failure and/or Circulatory Failure
Lead Sponsor:
Mahidol University
Conditions:
Severe Acute Respiratory Distress Syndrome
Refractory Hypoxemia
Eligibility:
All Genders
18+ years
Brief Summary
Extracorporeal membrane oxygenation (ECMO) had been used to treat refractory hypoxemia associated with acute respiratory distress syndrome (ARDS). There were reported good outcome associated with ECMO...
Detailed Description
This registry enroll refractory hypoxemia ARDS patients who met the criteria for veno-venous ECMO, according to 2013 Extracorporeal Life Support Organization (ELSO) guideline criteria. The definition ...
Eligibility Criteria
Inclusion
- Diagnosed ARDS according to Berlin criteria
- Refractory hypoxemia: PaO2/FiO2 \<100 with FiO2 \>90% despite optimal mechanical ventilator support and paralytic agent infusion
- Hypoxemia persist for at least 2 hours
Exclusion
- Terminally ill patient
- Patient who sign for do not resuscitation
- Metastatic malignancy
Key Trial Info
Start Date :
July 22 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04031794
Start Date
July 22 2019
End Date
July 31 2025
Last Update
September 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Siriraj Hospital
Bangkoknoi, Bangkok, Thailand, 10700